These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Monoclonal antibodies in the treatment of sepsis and septic shock]. Torrabadella de Reynoso P; Salgado Remigio A; Peracaula Picart R Med Clin (Barc); 1992 Dec; 99(20):784-92. PubMed ID: 1460952 [No Abstract] [Full Text] [Related]
3. "Monoclonal antibodies for septic shock: in or out of the barn door?". Goldstein B QRB Qual Rev Bull; 1992 Feb; 18(2):42. PubMed ID: 1574318 [No Abstract] [Full Text] [Related]
4. Therapies for sepsis. Emerging therapies for sepsis and septic shock. Abraham E West J Med; 1997 Mar; 166(3):195-200. PubMed ID: 9143195 [No Abstract] [Full Text] [Related]
5. [Monoclonal antibodies in the treatment of septic shock]. Trilla A; Alonso P Med Clin (Barc); 1992 Dec; 99(20):778-80. PubMed ID: 1460950 [No Abstract] [Full Text] [Related]
6. Monoclonal antibodies and the treatment of gram-negative bacteremia and shock. Wolff SM N Engl J Med; 1991 Feb; 324(7):486-8. PubMed ID: 1988835 [No Abstract] [Full Text] [Related]
7. The last round against bacterial infections? Marget W Infection; 1990; 18(4):197-9. PubMed ID: 2210849 [No Abstract] [Full Text] [Related]
8. [Is it possible to treat infections with non-antimicrobial agents?]. Gómez J; Ruiz-Gómez J; Herrero F Enferm Infecc Microbiol Clin; 1993 Dec; 11(10):519-21. PubMed ID: 8142499 [No Abstract] [Full Text] [Related]
9. Antiendotoxin antibodies: a dead end? Cross AS Ann Intern Med; 1994 Jul; 121(1):58-60. PubMed ID: 8198349 [No Abstract] [Full Text] [Related]
10. Therapies directed against endotoxin--has the time come? Quezado ZM; Hoffman WD West J Med; 1993 Apr; 158(4):424-5. PubMed ID: 8317138 [No Abstract] [Full Text] [Related]
11. Mechanism for monoclonal antibody mediated treatment of gram-negative shock. Torensma R; Fluit A Lancet; 1991 Jul; 338(8760):186. PubMed ID: 1677084 [No Abstract] [Full Text] [Related]
12. Survival in selected patients with gram-negative sepsis after adjunctive therapy with HA-1A. van Dissel JT; van Furth R; Compier BA; Feuth HD; Frolich M Lancet; 1993 Apr; 341(8850):959-60. PubMed ID: 8096292 [No Abstract] [Full Text] [Related]
15. [Treatment with monoclonal anti-endotoxin antibodies of patients with sepsis caused by Gram-negative bacteria]. Ned Tijdschr Geneeskd; 1991 Jul; 135(28):1289-91. PubMed ID: 1861770 [No Abstract] [Full Text] [Related]
16. Anatomy of an antibody, and related misadventures in developing an effective treatment for septic shock. Gibaldi M Pharmacotherapy; 1993; 13(4):302-8. PubMed ID: 8361858 [No Abstract] [Full Text] [Related]
17. Endotoxin in human disease. Part 2: Biologic effects and clinical evaluations of anti-endotoxin therapies. Manthous CA; Hall JB; Samsel RW Chest; 1993 Dec; 104(6):1872-81. PubMed ID: 8252975 [No Abstract] [Full Text] [Related]
18. Emerging therapies for sepsis and septic shock. Oh HM Ann Acad Med Singap; 1998 Sep; 27(5):738-43. PubMed ID: 9919353 [TBL] [Abstract][Full Text] [Related]
19. Anti-endotoxin therapy and the management of sepsis. Baumgartner JD J Antimicrob Chemother; 1992 Apr; 29(4):360-3. PubMed ID: 1607325 [No Abstract] [Full Text] [Related]
20. [Cytokines and septic shock. New perspectives on its treatment]. Zamora Madaria E An Med Interna; 1993 Dec; 10(12):573-5. PubMed ID: 8049320 [No Abstract] [Full Text] [Related] [Next] [New Search]